Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Pacific Biosciences of California Inc. (PacBio)

Headquarters: Menlo Park, CA, United States of America
Year Founded: 2004
Status: Public
Industry Sector: HealthTechnology
CEO: Christian O. Henry, MBA
Number Of Employees: N/A
Enterprise Value: $784,816,040
PE Ratio: -1.09
Exchange/Ticker 1: NASDAQ:PACB
Exchange/Ticker 2: N/A
Latest Market Cap: $334,114,112

BioCentury | Feb 5, 2025
Management Tracks

Management changes at Astellas

Plus: Lundbeck board planning to elect Dorothea Wenzel chair, and updates from PacBio and Uvax Bio
BioCentury | Jan 18, 2025
Data Byte

Takeout news crowns JPM’s winning stocks

Gainers, decliners among companies presenting at this week’s J.P. Morgan Healthcare Conference
BioCentury | Sep 3, 2024
Discovery & Translation

Neurology’s human data revolution

Back to School 2024 looks at how neuroscience companies are reducing to practice the concept of human-first discovery
BioCentury | Apr 5, 2024
Finance

1Q24 wrap: Red rising

Winners, losers in biotech stock tiers in 1Q24
BioCentury | Jan 26, 2023
Finance

Jan. 25 Finance Quick Takes: Pliant leads follow-on pack

Plus: Dimension launches with $350M fund for start-ups, and updates from Atomic AI
BioCentury | Dec 6, 2022
Data Byte

Pulmocide joins trio of start-ups with venture raises

Entact Bio, Vega mark debuts alongside $52M series C extension for U.K.’s Pulmocide
BioCentury | Aug 23, 2022
Management Tracks

Wigginton to lead R&D at Bright Peak

Plus: a Mythic farewell for Nichols, Biswas joins CDR-Life as CMO and updates from Brii, Ansa, Kyverna, AskBio and more
BioCentury | Jun 16, 2022
Management Tracks

New CEOs at Anjarium, Cambridge Epigenetix

Plus Sema4’s CFO to step down, and updates from Marengo, Avilar, City of Hope and more
BioCentury | May 18, 2022
Management Tracks

Fromen to leave PacBio as CCO

Plus Vraniak joins Inversago as CFO and updates from Thabor, Glympse, Civetta and more
BioCentury | Mar 9, 2022
Management Tracks

Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO

Plus updates from Centessa, Teon, AnchorDx, Pillar and more
Items per page:
1 - 10 of 73